Have chemosensitizing strategies for multidrug-resistant childhood acute lymphoblastic leukemia come of age?
作者信息
Bourquin Jean-Pierre, Bornhauser Beat
出版信息
Expert Rev Hematol. 2010 Aug;3(4):369-72. doi: 10.1586/ehm.10.39.
PMID:21083025
Abstract
摘要
相似文献
1
Have chemosensitizing strategies for multidrug-resistant childhood acute lymphoblastic leukemia come of age?
Expert Rev Hematol. 2010 Aug;3(4):369-72. doi: 10.1586/ehm.10.39.
2
Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
J Natl Cancer Inst. 2006 Oct 4;98(19):1363-74. doi: 10.1093/jnci/djj372.
3
Connecting the dots using gene-expression profiles.
N Engl J Med. 2006 Nov 9;355(19):2042-4. doi: 10.1056/NEJMcibr065953.
4
Building better therapy for children with acute lymphoblastic leukemia.
Cancer Cell. 2005 Apr;7(4):289-91. doi: 10.1016/j.ccr.2005.04.003.
5
Pharmacology and drug resistance in childhood lymphoblastic leukemia.
Hematol Oncol Clin North Am. 1990 Oct;4(5):871-94.
6
Quest for effective agents to combat T-cell acute lymphoblastic leukemia.
Eur J Cancer. 2005 Jun;41(9):1243-5. doi: 10.1016/j.ejca.2005.03.008.
7
Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
Int J Oncol. 2003 Aug;23(2):509-17.
8
St Jude researchers use DNA chips to determine how leukemia cells responds to different drug treatments.
Pharmacogenomics. 2003 May;4(3):244.
9
In vitro comparative antileukemic activity of various glucocorticoids in childhood acute leukemia.
Neoplasma. 2002;49(3):178-83.
10
Obinutuzumab in multidrug-resistant hairy cell leukemia.
Ann Hematol. 2016 Jan;95(2):351-2. doi: 10.1007/s00277-015-2520-y. Epub 2015 Oct 7.
Zotero 插件